ResearchComparative risk of postoperative complications in ulcerative colitis patients following preoperative advanced therapies: a network meta-analysis with meta-regression
Oct 15, 2026Original ArticlePhase 2 Trial of Icotrokinra for Patients with Ulcerative ColitisWritten by 1 Roon author & 19 others Via The New England Journal of Medicine
ResearchBenefit-Risk Profile of Upadacitinib: Exploratory Post Hoc Analysis of Phase 2b/3 Studies in Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
ResearchForecasting the Incidence and Prevalence of Inflammatory Bowel Disease Across Nine Epidemiologic Stage 3 Regions
ResearchAGA Clinical Practice Update on Inpatient Management of Adults With Inflammatory Bowel Disease: Expert Review
ResearchEfficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn's Disease
ResearchIOIBD Evidence-Based Consensus on the Use of Artificial Intelligence for Assessment of Endoscopic and Histologic Endpoints in Clinical Trials of Inflammatory Bowel Disease
ResearchImpact of Mirikizumab on Patient-Reported Outcomes and Quality of Life in Patients With Crohn's Disease: Results From the Phase 2 SERENITY Study
ResearchOral Vancomycin Is an Effective Therapy in Adult Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
ResearchSymptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial
ResearchImprovement in Health-Related Quality of Life in Patients With Moderate to Severe Crohn's Disease Treated With Risankizumab Versus Ustekinumab in the Phase 3B SEQUENCE Study
ResearchMagnetic Resonance Imaging for Distinguishing Perianal Hidradenitis Suppurativa from Fistulizing Crohn Disease
ResearchCertolizumab Pegol Treatment in Patients With Crohn's Disease: Final Safety Data From the SECURE Registry
ResearchInduction of Endoscopic Response, Remission, and Ulcer-Free Endoscopy With Upadacitinib Is Associated With Improved Clinical Outcomes and Quality of Life in Patients With Crohn's Disease